ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease

Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was 'definitively neutral' in patients with heart disease but no gout.
Medscape Medical News

source https://www.medscape.com/viewarticle/979859?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost